KLOW
Also known as: KPV + BPC-157 + TB-500 + GHK-Cu
A four-peptide healing and recovery blend that combines KPV, BPC-157, TB-500, and GHK-Cu in a single injection. Each component covers a different repair pathway — KPV for inflammation control, BPC-157 for tissue and gut healing, TB-500 for cell migration, and GHK-Cu for collagen remodelling. Has built a significant Reddit and biohacker following in 2026 for skin, hair, and recovery applications. Available exclusively through compounding pharmacies.
Blend Composition
| Ingredient | Amount |
|---|---|
| KPV (Lys-Pro-Val) | 250 mcg |
| BPC-157 | 250 mcg |
| TB-500 (Thymosin Beta-4 fragment) | 250 mcg |
| GHK-Cu (Copper Peptide) | 1 mg |
Typical formulation — exact composition varies by supplier.
Dosage
Fixed compounded dose: ~250 mcg each peptide + 1 mg GHK-Cu subcutaneous daily
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Half-Life
Component half-lives: KPV ~1 hour | BPC-157 ~4 hours | TB-500 ~2-3 hours | GHK-Cu ~1-2 hours
Half-Life Calculator →Administration
Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Tissue Repair
Four-component blend layering KPV, BPC-157, TB-500, and GHK-Cu across the full healing cascade.
Hair & Skin
Reddit-trending in 2026 for hair regrowth and skin quality — additive KPV anti-inflammatory + GHK-Cu effects.
Anti-Inflammatory
KPV downregulates NF-kB inflammation pathway alongside the other components.
Collagen Remodelling
GHK-Cu component activates lysyl oxidase for properly cross-linked collagen formation.
Mechanism of Action
KLOW is a four-component compounded blend designed to layer four mechanistically distinct healing pathways into a single injection — KPV for anti-inflammatory and immune modulation, BPC-157 for vascular and growth factor signalling, TB-500 for cell migration and cytoskeletal dynamics, and GHK-Cu for collagen synthesis and copper-dependent tissue remodelling.
The theoretical sequencing of action covers the full wound-healing cascade. KPV (a tripeptide derived from alpha-MSH) suppresses inflammatory cytokine production via the melanocortin pathway and downregulates NF-kB signalling, calming acute inflammation without immunosuppressing infection control. BPC-157 then drives the proliferative phase by upregulating VEGF-mediated angiogenesis, activating eNOS for nitric oxide signalling, and recruiting fibroblasts to injury sites. TB-500 (thymosin beta-4) sequesters G-actin monomers to facilitate cell migration, allowing repair cells (endothelial progenitors, fibroblasts, keratinocytes) to physically reach injury sites. GHK-Cu (the copper-binding tripeptide) supports the remodelling phase by activating lysyl oxidase to cross-link new collagen and elastin into properly organised, functional tissue rather than disorganised scar.
The combination has gained significant traction on Reddit and in biohacker communities in 2026, particularly for hair regrowth (where the KPV anti-inflammatory and GHK-Cu hair-follicle effects appear additive), skin quality, and post-injury recovery. As with all multi-peptide compounded blends, no controlled clinical trials exist for KLOW specifically — the rationale is built from each component's individual mechanistic profile rather than direct combination data, and inter-component interactions and cumulative safety remain uncharacterised. KLOW is exclusively a compounded preparation, with formulation and quality control varying meaningfully between compounding pharmacies.
Regulatory Status
Not FDA approved. Available only through compounding pharmacies. Quality and exact ratios vary by supplier.
Risks & Safety
Common
injection site irritation, mild fatigue or headache, occasional flushing from GHK-Cu.
Serious
theoretical risk of accelerating existing tumour growth (multiple components stimulate angiogenesis and cell proliferation); cumulative immune-modulating effects of four bioactive peptides used together are not clinically characterised.
Rare
allergic reactions, potential copper-related effects from chronic GHK-Cu exposure. No clinical trial data exists for this specific combination.
Compare KLOW With
Research Papers
No research papers indexed yet. Papers are fetched from PubMed weekly.
Frequently Asked Questions
What is KLOW?
A four-peptide healing and recovery blend that combines KPV, BPC-157, TB-500, and GHK-Cu in a single injection. Each component covers a different repair pathway — KPV for inflammation control, BPC-157 for tissue and gut healing, TB-500 for cell migration, and GHK-Cu for collagen remodelling. Has built a significant Reddit and biohacker following in 2026 for skin, hair, and recovery applications. Available exclusively through compounding pharmacies.
What is KLOW used for?
A four-peptide healing and recovery blend that combines KPV, BPC-157, TB-500, and GHK-Cu in a single injection. Each component covers a different repair pathway — KPV for inflammation control, BPC-157 for tissue and gut healing, TB-500 for cell migration, and GHK-Cu for collagen remodelling. Has built a significant Reddit and biohacker following in 2026 for skin, hair, and recovery applications. Available exclusively through compounding pharmacies.
What is the dosage for KLOW?
Standard compounded dose: KPV 250 mcg + BPC-157 250 mcg + TB-500 250 mcg + GHK-Cu 1 mg subcutaneous once daily for 4-8 weeks, then taper to two or three times weekly maintenance. Dose ratios vary by compounding pharmacy. No standardised clinical protocol exists.
What are the side effects of KLOW?
Common: injection site irritation, mild fatigue or headache, occasional flushing from GHK-Cu. Serious: theoretical risk of accelerating existing tumour growth (multiple components stimulate angiogenesis and cell proliferation); cumulative immune-modulating effects of four bioactive peptides used together are not clinically characterised. Rare: allergic reactions, potential copper-related effects from chronic GHK-Cu exposure. No clinical trial data exists for this specific combination.
How does KLOW work?
KLOW is a four-component compounded blend designed to layer four mechanistically distinct healing pathways into a single injection — KPV for anti-inflammatory and immune modulation, BPC-157 for vascular and growth factor signalling, TB-500 for cell migration and cytoskeletal dynamics, and GHK-Cu for collagen synthesis and copper-dependent tissue remodelling. The theoretical sequencing of action covers the full wound-healing cascade. KPV (a tripeptide derived from alpha-MSH) suppresses inflammatory cytokine production via the melanocortin pathway and downregulates NF-kB signalling, calming acute inflammation without immunosuppressing infection control. BPC-157 then drives the proliferative phase by upregulating VEGF-mediated angiogenesis, activating eNOS for nitric oxide signalling, and recruiting fibroblasts to injury sites. TB-500 (thymosin beta-4) sequesters G-actin monomers to facilitate cell migration, allowing repair cells (endothelial progenitors, fibroblasts, keratinocytes) to physically reach injury sites. GHK-Cu (the copper-binding tripeptide) supports the remodelling phase by activating lysyl oxidase to cross-link new collagen and elastin into properly organised, functional tissue rather than disorganised scar. The combination has gained significant traction on Reddit and in biohacker communities in 2026, particularly for hair regrowth (where the KPV anti-inflammatory and GHK-Cu hair-follicle effects appear additive), skin quality, and post-injury recovery. As with all multi-peptide compounded blends, no controlled clinical trials exist for KLOW specifically — the rationale is built from each component's individual mechanistic profile rather than direct combination data, and inter-component interactions and cumulative safety remain uncharacterised. KLOW is exclusively a compounded preparation, with formulation and quality control varying meaningfully between compounding pharmacies.
How is KLOW administered?
KLOW is administered via subcutaneous injection.
What is the half-life of KLOW?
The half-life of KLOW is Component half-lives: KPV ~1 hour | BPC-157 ~4 hours | TB-500 ~2-3 hours | GHK-Cu ~1-2 hours.
Is KLOW legal?
Not FDA approved. Available only through compounding pharmacies. Quality and exact ratios vary by supplier.
Sources. This profile is built from peer-reviewed papers indexed on PubMed, FDA-approved labelling where available, and published clinical guidelines. See our editorial standards for how we research and review peptide profiles.
Last reviewed. by the Peptide Reference Editorial Team. Spot an error? Email a correction.
Not medical advice. Information on this page is for educational and research reference only. Many peptides covered are not approved for human use. See our full medical disclaimer.
Related Peptides
Ara-290
A peptide derived from EPO (the hormone that boosts red blood cells) but engineered to keep only the tissue-protective effects — it doesn't increase red blood cells at all. It activates the body's repair receptors to protect tissues and regenerate nerves. Particularly promising for nerve damage and tissue injury from poor blood flow. People use it for diabetic nerve damage and similar conditions.
Botulinum Toxin
A toxin produced by bacteria — the most potent biological toxin known, yet one of the most widely used cosmetic and medical treatments globally. In carefully controlled doses, it temporarily relaxes targeted muscles by blocking the signal that tells muscles to contract. Approved for cosmetic wrinkle reduction and many medical conditions including chronic migraine, excessive sweating, and neck muscle spasms. People use it for forehead lines, crow's feet, frown lines, and various medical conditions.
BPC-157
A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.
BPC-157 + TB-500
A two-in-one product that pairs BPC-157 and TB-500 to target different healing pathways. BPC-157 focuses on gut, tendon, and ligament repair by supporting blood vessel growth and nitric oxide signaling, while TB-500 helps cells move to injury sites for body-wide tissue repair. The most popular peptide combination for healing and recovery.